ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

ClinicalTrials.gov ID: NCT06309992

Public ClinicalTrials.gov record NCT06309992. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicentre, Randomised, Double-blind, Placebo-controlled, 48-week, Phase III Trial to Evaluate the Efficacy and Safety of Survodutide Administered Subcutaneously in Participants With Overweight or Obesity and Presumed or Confirmed Nonalcoholic Steatohepatitis (NASH)

Study identification

NCT ID
NCT06309992
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
218 participants

Conditions and interventions

Interventions

  • Placebo Combination Product
  • Survodutide Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2024
Primary completion
Oct 8, 2025
Completion
Dec 1, 2025
Last update posted
Apr 29, 2026

2024 – 2025

United States locations

U.S. sites
33
U.S. states
12
U.S. cities
32
Facility City State ZIP Site status
ARK Clinical Research Fountain Valley California 92708
Velocity Clinical Research-Gardena-69773 Gardena California 90247
ARK Clinical Research Long Beach California 92657
Catalina Research Institute, LLC Montclair California 91763
Velocity Clinical Research-North Hollywood-69852 North Hollywood California 91606
Velocity Clinical Research-Panorama City-68861 Panorama City California 91402
Velocity Clinical Research, Santa Ana Santa Ana California 92704
Excel Medical Clinical Trials Boca Raton Florida 33434
Segal Drug Trials Delray Beach Florida 33484
Fleming Island Center for Clinical Research Fleming Island Florida 32003
Covenant Metabolic Specialists, LLC - Fort Myers Fort Myers Florida 33912
Velocity Clinical Research-Hallandale Beach-67888 Hallandale Florida 33009
Nature Coast Clinical Research-Inverness-48221 Inverness Florida 34452
Health Awareness, Inc. Jupiter Florida 33458
Verus Clinical Research Corporation Miami Florida 33135
Panax Clinical Research Miami Lakes Florida 33014
Covenant Research and Clinics, LLC Sarasota Florida 34240
Springfield Clinic, LLP Springfield Illinois 62702
Indiana University Indianapolis Indiana 46202
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Kansas Medical Clinic PA Topeka Kansas 66606-1707
Louisiana Research Center, LLC Shreveport Louisiana 71105
Washington University School of Medicine St Louis Missouri 63110
DSI Research Northridge LLC Dayton Ohio 45414
Medical University of South Carolina Charleston South Carolina 29425
Velocity Clinical Research, Austin Austin Texas 78759
Amel Med LLC Georgetown Texas 78628
Gastroenterology and Liver Research LLC Houston Texas 77043
Biopharma Informatic, Inc. Research Center Houston Texas 77084
Accurate Clinical Research, Inc. Humble Texas 77346
Clinical Trials of Texas, LLC San Antonio Texas 78229
Velocity Clinical Research, Waco Waco Texas 76710
GI Select Health Research LLC Richmond Virginia 23236

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06309992, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06309992 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →